| This week's sponsor is Premier Research. | | | Taking the Fight to Rare Cancers
Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for biotech. |
Today's Rundown Tocagen fails brain cancer test, sets about 'operational review' as shares routed Moderna guides 2 mRNA assets through early clinical tests 'No surprise'—FDA sticks to the script ahead of Aimmune peanut allergy AdComm [Sponsored] What Makes an Oncology Clinical Trial Site Stand Out from the Competition? Roche's satralizumab cuts relapse risk in rare disease phase 3 J&J multiple sclerosis hopeful tops Sanofi's Aubagio at reducing relapse, fatigue Many cancer drugs don't hit their intended targets: study Featured Story | | | Thursday, September 12, 2019 It was always going to be a long shot, given how tough brain cancer is to treat and the litany of failures left in its wake, but Tocagen, perhaps inevitably, has seen its attempt flop, leading to a review of its operations. |
|
|---|
|
Top Stories Thursday, September 12, 2019 Moderna has shared data from two phase 1 trials of mRNA candidates, providing early evidence it could succeed in making its own drugs. The trials tested cytomegalovirus vaccine mRNA-1647 and chikungunya virus candidate mRNA-1944. Thursday, September 12, 2019 “Briefing docs right down the middle of the fairway,” wrote Piper Jaffray analysts of Aimmune's peanut allergy treatment, Palforzia. The Allergenic Products Advisory Committee will meet on Friday to review the treatment. Monday, September 9, 2019 Patients want the best cancer therapies, and sites that enable clinical trials are the ones that can access those new drugs faster. Here’s how Thursday, September 12, 2019 In a phase 3 trial of its neuromyelitis optica spectrum disorder treatment satralizumab, Roche linked the anti-IL-6 antibody to a 55% reduction in the risk of relapse, showing the drug works but with scope to question how it will do against rivals. Wednesday, September 11, 2019 In a study testing a 20 mg dose of Janssen's multiple sclerosis drug ponesimod against a 14 mg dose of Sanofi's Aubagio in adults with the relapsing form of the disease, ponesimod cut the number of disease flare-ups by 30%. Wednesday, September 11, 2019 Several cancer drug candidates in clinical trials are designed to kill tumor cells by attacking certain targets, but they actually work in other ways, a study by Cold Spring Harbor Laboratory has found. Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. U.S. Healthcare Compliance Certificate Program October 14-17, 2019 | Newark, New Jersey European Healthcare Compliance Certificate Program October 21-25, 2019 | Paris, France BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 